Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | Omeros Corpnote 5.250% 2/1 | $44,643,626 | -15.4% | 72,979,000 | +1.4% | 39.31% | +14.9% | |
| Sell | Biora Inc.note 7.250% 12/0 | $27,960,943 | -53.8% | 53,500,000 | -48.3% | 24.62% | -37.2% | |
| Buy | Biora Inc. | $23,717,584 | +263.6% | 10,929,762 | +545.0% | 20.89% | +393.5% | |
| Exit | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $0 | – | -9,000,000 | – | -5.74% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Biora Inc.note 7.250% 12/0 | $60,477,148 | – | 103,500,000 | – | 39.23% | – | |
| New | Omeros Corpnote 5.250% 2/1 | $52,755,389 | – | 71,979,000 | – | 34.22% | – | |
| New | Omeros Corpnote 6.250%11/1 | $11,037,382 | – | 11,005,000 | – | 7.16% | – | |
| New | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $8,848,843 | – | 9,000,000 | – | 5.74% | – | |
| OSMT | New | RVL PHARMACEUTICALS PLC | $8,177,709 | – | 14,600,444 | – | 5.30% | – |
| New | Biora Inc. | $6,523,751 | – | 1,694,481 | – | 4.23% | – | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $6,326,162 | – | 1,792,114 | – | 4.10% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REPH | Exit | Societal CDMO Inc. | $0 | – | -2,202,420 | – | -1.34% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -1,792,114 | – | -1.59% | – |
| Exit | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $0 | – | -9,000,000 | – | -3.00% | – | |
| Exit | BridgeBio Pharma Inc.note 2.250% 2/0 | $0 | – | -20,000,000 | – | -3.26% | – | |
| PROG | Exit | Biora Inc. | $0 | – | -29,855,847 | – | -5.42% | – |
| Exit | Omeros Corpnote 6.250%11/1 | $0 | – | -21,005,000 | – | -7.21% | – | |
| Exit | Omeros Corpnote 5.250% 2/1 | $0 | – | -40,150,000 | – | -8.36% | – | |
| OSMT | Exit | RVL PHARMACEUTICALS PLC | $0 | – | -14,600,444 | – | -11.48% | – |
| CMAX | Exit | CAREMAX INC | $0 | – | -4,467,219 | – | -11.86% | – |
| AMYT | Exit | Amryt Pharma PLCsponsored ads | $0 | – | -8,857,268 | – | -22.96% | – |
| Exit | Biora Inc.note 7.250% 12/0 | $0 | – | -103,500,000 | – | -23.51% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMAX | Sell | CAREMAX INC | $31,673,000 | +94.4% | 4,467,219 | -0.4% | 11.86% | +73.1% |
| OSMT | Buy | RVL PHARMACEUTICALS PLC | $30,661,000 | +176.7% | 14,600,444 | +79.2% | 11.48% | +146.4% |
| Buy | Omeros Corpnote 5.250% 2/1 | $22,336,000 | +10.1% | 40,150,000 | +14.2% | 8.36% | -2.0% | |
| New | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $8,000,000 | – | 9,000,000 | – | 3.00% | – | |
| Exit | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $0 | – | -9,000,000 | – | -3.31% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Biora Inc.note 7.250% 12/0 | $65,534,000 | – | 103,500,000 | – | 27.56% | – | |
| AMYT | New | Amryt Pharma PLCsponsored ads | $61,912,000 | – | 8,857,268 | – | 26.04% | – |
| PROG | New | Biora Inc. | $20,899,000 | – | 29,855,847 | – | 8.79% | – |
| New | Omeros Corpnote 5.250% 2/1 | $20,284,000 | – | 35,150,000 | – | 8.53% | – | |
| New | Omeros Corpnote 6.250%11/1 | $18,642,000 | – | 21,005,000 | – | 7.84% | – | |
| CMAX | New | CAREMAX INC | $16,289,000 | – | 4,487,219 | – | 6.85% | – |
| OSMT | New | RVL PHARMACEUTICALS PLC | $11,082,000 | – | 8,148,832 | – | 4.66% | – |
| New | BridgeBio Pharma Inc.note 2.250% 2/0 | $8,393,000 | – | 20,000,000 | – | 3.53% | – | |
| New | Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $7,860,000 | – | 9,000,000 | – | 3.31% | – | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $5,108,000 | – | 1,792,114 | – | 2.15% | – |
| REPH | New | Societal CDMO Inc. | $1,751,000 | – | 2,202,420 | – | 0.74% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REPH | Exit | Recro Pharma Inc. | $0 | – | -2,202,420 | – | -2.88% | – |
| CMAX | Exit | CAREMAX INC | $0 | – | -4,487,220 | – | -27.50% | – |
| AMYT | Exit | Amryt Pharma PLCsponsored ads | $0 | – | -4,520,000 | – | -34.53% | – |
| PROG | Exit | Progenity Inc. | $0 | – | -36,396,907 | – | -35.09% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMAX | Buy | CAREMAX INC | $43,347,000 | -13.3% | 4,487,220 | +15.8% | 27.50% | +31.9% |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PROG | New | Progenity Inc. | $129,937,000 | – | 36,396,907 | – | 54.17% | – |
| AMYT | New | Amryt Pharma PLCsponsored ads | $54,828,000 | – | 4,520,000 | – | 22.86% | – |
| CMAX | New | CAREMAX INC | $50,008,000 | – | 3,876,568 | – | 20.85% | – |
| REPH | New | Recro Pharma Inc. | $5,088,000 | – | 2,202,420 | – | 2.12% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -1,333,333 | – | -100.00% | – |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KALA | New | KALA PHARMACEUTICALS INC | $8,507,000 | – | 1,333,333 | – | 100.00% | – |
Q4 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -252,079 | – | -1.44% | – |
| Exit | PTC THERAPEUTICS INCnote 3.000% 8/1 | $0 | – | -23,067,000 | – | -21.23% | – | |
| Exit | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $0 | – | -133,337,000 | – | -77.33% | – |
Q3 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $96,801,000 | +54.7% | 133,337,000 | +40.3% | 77.33% | +14.3% | |
| Sell | PTC THERAPEUTICS INCnote 3.000% 8/1 | $26,578,000 | -5.5% | 23,067,000 | -17.8% | 21.23% | -30.2% |
Q2 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $62,588,000 | – | 95,045,000 | – | 67.68% | – | |
| New | PTC THERAPEUTICS INCnote 3.000% 8/1 | $28,135,000 | – | 28,067,000 | – | 30.42% | – | |
| APEN | New | APOLLO ENDOSURGERY INC | $1,760,000 | – | 252,079 | – | 1.90% | – |